Nature of Disclosure: This is a formal notice to the Bombay Stock Exchange (BSE) regarding an upcoming meeting of the Board of Directors of Samrat Pharmachem Limited.
Key Event: A Board Meeting is scheduled to be held on Friday, August 14, 2026, at 02:00 P.M.
Location: The meeting will take place at the Corporate Office of the Company, located at 701/702, Business Square, M. A. Road, Andheri (West), Mumbai – 400058.
Primary Agenda: The Board will consider and take on record the Un-Audited Financial Results of the Company for the quarter ended June 30, 2026. These results will be prepared under Indian Accounting Standards (Ind-AS).
Regulatory Compliance: The notice is issued pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Furthermore, in accordance with Regulation 46, the notice of the Board meeting will be made available on the company's website at www.samratpharmachem.com.
Post-Meeting Actions: The company will intimate the exchanges with the Un-Audited Financial Results upon conclusion of the Board Meeting. The company will also arrange for the announcement of the results in the Press and on the company's website as required under the Listing Agreement.
Authorized Signatory: The notice is signed by Nishant Kankaria, Company Secretary & Compliance Officer.